ONEBIO LABS / RESEARCH INFORMATION
SS-31
Research Peptide | Elamipretide / Mitochondria-Targeted Tetrapeptide
Technical specifications
| Common name | SS-31 / Elamipretide |
|---|---|
| Classification | Mitochondria-targeted tetrapeptide |
| Common research form | Free peptide or TFA salt; exact form per COA |
| Target context | Mitochondrial membrane / cardiolipin-associated research |
| Form | Lyophilised peptide |
| Purity / testing | Refer to product-specific batch COA / analytical documentation |
| Intended use | Laboratory and research purposes only |
Free peptide and TFA salt records differ; use the exact batch identity for formula, molecular weight and CAS information.
01 / PRODUCT INFORMATION
Product description
SS-31, also known as elamipretide, is a mitochondria-targeted tetrapeptide investigated for interactions with mitochondrial membranes and cardiolipin-associated processes. Research focuses on mitochondrial bioenergetics and oxidative-stress pathways.
02 / RESEARCH CONTEXT
Research overview
Research areas: Mitochondrial bioenergetics; cardiolipin-associated biology; oxidative stress; cellular energy research.
03 / PRODUCT INFORMATION
ONE BIOLABS quality
ONE BIOLABS provides research products with product information and available batch documentation where applicable. Batch-specific identity, purity, concentration, salt form, testing and manufacturing claims should be stated only where supported by the applicable Certificate of Analysis or other analytical documentation.
04 / STORAGE
Refrigerate at 2–8°C
Unless the product-specific label or Certificate of Analysis states otherwise, store refrigerated at 2–8°C, protected from direct light, excessive heat and moisture. Keep the container securely closed. Product-specific storage instructions and stability data should take precedence.
Important notice
FOR RESEARCH PURPOSES ONLY. This product information is intended for laboratory and research reference. Products described in this document are not intended for human consumption, self-administration, diagnosis, treatment, prevention or cure of disease unless supplied as an appropriately authorised medicinal product through lawful channels. No dosage, administration or therapeutic guidance is provided.
Research findings, especially preclinical findings, should not be interpreted as proof of human safety or efficacy.
Reviews
There are no reviews yet.